Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
08/21/1991 | EP0442724A2 Modified hIL-6 |
08/21/1991 | EP0442671A2 Prolonged release microcapsules |
08/21/1991 | EP0442538A1 High purified protein, production and use thereof |
08/21/1991 | EP0442140A1 Dietetic food for patients with renal insufficiency |
08/21/1991 | EP0441939A1 Wound healing |
08/21/1991 | EP0441889A1 Modified human growth hormone |
08/21/1991 | EP0441882A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
08/21/1991 | EP0441871A1 A sheet feeding apparatus |
08/21/1991 | EP0441832A1 Composition and treatment with biologically active peptides and certain anions. |
08/21/1991 | EP0403605A4 Elastase inhibiting polymers and methods |
08/21/1991 | EP0365657A4 Dna encoding androgen receptor protein |
08/20/1991 | WO1991012265A1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
08/20/1991 | US5041538 Mammalian follistatin |
08/20/1991 | US5041537 Method of preparing a high-purity, virus safe, biologically active transferrin preparation |
08/20/1991 | US5041535 Antileukemic and immunostimulant peptides |
08/20/1991 | US5041534 Process for preparing antibiotic L 17054 |
08/20/1991 | US5041533 Hinge peptide, a process for its manufacture, and its use for the manufacture of synthetic immunogens |
08/20/1991 | US5041423 Antibiotics of the mureidomycin group, their preparation, and their therapeutic use |
08/20/1991 | US5041381 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
08/20/1991 | US5041380 Tetrapeptide |
08/20/1991 | US5041291 Biodegradable poly(hydroxyalkyl)amino dicarboxylic acid) derivatives, a process for their preparation, and the use thereof for depot formulations with controlled deivery of active ingredient |
08/20/1991 | US5041288 Method of treating tissue damaged by reperfusion injury |
08/20/1991 | US5041236 Antimicrobial methods and compositions employing certain lysozymes and endoglycosidases |
08/20/1991 | CA2069087A1 N-phenyl n-alcoxycarbonylalkylglycinamides, their preparation and medicaments containing them |
08/20/1991 | CA1287811C Antihuman pulmonary adenocarcinoma monoclonal antibody |
08/17/1991 | WO1991012017A1 Heparin neutralization with platelet factor 4 |
08/17/1991 | CA2075957A1 Heparin neutralization with platelet factor 4 |
08/17/1991 | CA2075927A1 Hybrid reagents capable of selectively releasing molecules into cells |
08/17/1991 | CA2036345A1 Peptide analogues |
08/16/1991 | WO1991012322A1 COVALENT ANGIOGENIN/RNase HYBRIDS |
08/16/1991 | WO1991012245A1 4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same |
08/16/1991 | CA2073434A1 Covalent angiogenin/rnase hybrids |
08/16/1991 | CA2051115A1 4h-3,1-benzoxazin-4-one compounds and their pharmaceutical compositions for inhibiting elastase |
08/16/1991 | CA2035987A1 Non-biodegradable, two-phase corneal implant and method for preparing same |
08/15/1991 | WO1991012332A1 Monoclonal antibodies for recognizing a peptide linked to a major histocompatibility antigen |
08/15/1991 | CA2051651A1 Monoclonal antibodies recognizing a peptide associated with a major histocompatibility antigen |
08/14/1991 | EP0441695A1 Procedure for preparing human factor VIII and analogs thereof |
08/14/1991 | EP0441395A2 Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections |
08/14/1991 | EP0441274A2 Process for the purification of lipocortins |
08/14/1991 | EP0441192A2 Retroisosteric dipeptides, their preparation and use as renin inhibitors in pharmaceutical compositions |
08/14/1991 | EP0441191A2 Retroisosteric dipeptides, their preparation and use as renin inhibitors in pharmaceutical compositions |
08/14/1991 | EP0440989A1 A method for preparing a dried composition of insulin-like growth factor I (IGF-I) |
08/14/1991 | EP0440763A1 t-PA MUTANT GK1L. |
08/14/1991 | EP0440744A1 Products and methods for controlling the suppression of the neoplastic phenotype |
08/14/1991 | EP0440709A1 Thrombolytic agents with modified kringle domains. |
08/14/1991 | EP0440693A1 Gynaecological procedure |
08/14/1991 | DE4010645A1 New synthetic peptide thymosin alpha-MDP-lysine - and similar compounds, useful to treat auto:immune diseases e.g. myasthenia gravis, multiple sclerosis and AIDs |
08/14/1991 | DE4003815A1 Bakterielle peptidfraktion mit immunstimulierender wirkung, verfahren zur herstellung derselben und ihre verwendung Bacterial peptide fraction having immunostimulating activity, processes for the preparation thereof and their use |
08/13/1991 | US5039805 Novel benzoic and phenylacetic acid derivatives |
08/13/1991 | US5039794 Tumor egress factor and processes for producing the same |
08/13/1991 | US5039791 Peptide fragments of tissue plasminogen activator |
08/13/1991 | US5039790 Bioactive fragment of interleukin-1-B that has antagonistic activity |
08/13/1991 | US5039789 Antibacterial agents |
08/13/1991 | US5039662 Pentapeptide containing tyrosine, isoleucine, glycine serine, and arginine |
08/13/1991 | US5039609 low molecular weight peptides in aqueous solution; from enzymatic hydrolysis of proteins, purity, controlled concentration |
08/13/1991 | US5039532 Preparation of a hypoallergenic whey protein hydrolyzate and food |
08/13/1991 | US5039523 Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
08/13/1991 | US5039521 Immune cell proliferation inhibitors |
08/13/1991 | US5039520 Blood extenders, dextran, hydroxyethyl starch, albumin, hemoglobins, ethylene oxide-propylene oxide copolymer |
08/13/1991 | CA2036007A1 Cytotoxic n, n'-bis (succinyl-peptide)-derivatives of 1,4-bis (aminoalkyl)-5,8-dihydroxyanthraquinones and antibody conjugates thereof |
08/13/1991 | CA1287578C Anti-human ovarian cancer immunotoxins and methods of use thereof |
08/13/1991 | CA1287577C Growth promoting compositions |
08/10/1991 | WO1991012267A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
08/10/1991 | WO1991012264A1 N-phenyl n-acetamido glycinamides, preparation method and drugs containing them |
08/10/1991 | CA2075705A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof |
08/10/1991 | CA2072981A1 N-phenyl n-acetamido glycinamides, their preparation and drugs holding same |
08/09/1991 | CA2035959A1 Peptide compositions and uses therefor |
08/09/1991 | CA2035927A1 Process for purifying lipocortins |
08/09/1991 | CA2035848A1 Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infectins |
08/08/1991 | WO1991012327A1 Glutathione-s-transferase sm26 of s. mansoni |
08/08/1991 | WO1991011535A1 Inhibition of transcription by double-stranded oligonucleotides |
08/08/1991 | WO1991011515A2 Leukocyte-derived growth factor |
08/08/1991 | WO1991011463A1 Endogenous brain factor, method for obtaining it and therapeutic and diagnostic uses thereof |
08/08/1991 | WO1991011459A1 Extracellular form of the human fibroblast growth factor receptor |
08/08/1991 | WO1991011457A1 Glp-1 analogs useful for diabetes treatment |
08/08/1991 | WO1991011456A1 EXTRACELLULAR SEGMENTS OF HUMAN ε IMMUNOGLOBULIN ANCHORING PEPTIDES AND ANTIBODIES SPECIFIC THEREFOR |
08/08/1991 | WO1991011455A1 Phorbol ester receptor |
08/08/1991 | WO1991011205A1 Mannuronic acid containing alginate wound healing composition and method |
08/08/1991 | WO1991011200A1 Improved cyclodextrin based erythropoietin formulation |
08/08/1991 | WO1991011196A1 A method of treating a mammal with a biologically active compound |
08/08/1991 | WO1991011195A1 A method of treating a mammal with a biologically active compound |
08/08/1991 | WO1991011180A1 Method of treating cancer using structured lipids |
08/08/1991 | WO1991011174A1 Method for preventing immune suppression in trauma patients |
08/08/1991 | WO1991009958A3 Method of delivering molecules into eukaryotic cells |
08/08/1991 | WO1991005536A3 Novel oxidized lipoproteins and methods for their preparation |
08/08/1991 | DE4002981A1 Epididymis-specific DNA sequences |
08/08/1991 | DE3938140A1 Desodorierende kosmetische mittel Deodorizing cosmetic medium |
08/08/1991 | CA2075196A1 Leukocyte-derived growth factor |
08/08/1991 | CA2074492A1 Method of treating cancer using structure lipids |
08/08/1991 | CA2051695A1 Glutathion-s-transferase sm26 of s. mansoni |
08/07/1991 | WO1991012022A1 Immune complexes |
08/07/1991 | WO1991012013A1 CYCLIC GnRH ANTAGONISTS |
08/07/1991 | EP0440483A2 Process for purifying immune serum globulins |
08/07/1991 | EP0440351A2 Recombinant human anti-CD18 antibodies |
08/07/1991 | EP0440333A2 Dopamine agonists for treating type II diabetes |
08/07/1991 | EP0440321A2 Epididymis specific DNA sequences and their use |
08/07/1991 | EP0440311A1 A process for the production of alpha-human atrial natriuretic polypeptide |
08/07/1991 | EP0440309A1 Pharmaceutical and dietary composition |
08/07/1991 | EP0440308A1 Pharmaceutical and dietary composition |
08/07/1991 | EP0440307A2 Pharmaceutical and dietary composition |